A data analysis from a randomized clinical trial for stage 3 colon cancer patients found that patients with evidence of residual cancer in their blood after surgery to remove the cancer, may benefit ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...

PALO ALTO, Calif. - Scilex Holding Company (NASDAQ:SCLX), a pharmaceutical company with a current market capitalization of ...

In addition to ZTlido, Scilex's portfolio features Elyxyb, an oral celecoxib solution for migraines, which may also find broader use for acute pain such as tension headaches. Another product ...

Neuroblastoma is the most common extracranial solid tumor in children, with nearly 50% of cases diagnosed at an advanced ...

Here are the most anticipated abstracts to keep an eye on going into the 2025 ASCO Gastrointestinal Cancers Symposium.

Although ctDNA positivity generally meant worse disease-free survival in stage 3 resected colon cancer, patients with ctDNA ...

Neuroblastoma is the most common extracranial solid tumor in children, with nearly 50% of cases diagnosed at an advanced stage, often with metastatic disease.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...